Maintenance Zanzalintinib With Etoposide After HDCT in GCT

Clinical trial NCT06937866 · RECRUITING

Trial details

NCT number: NCT06937866
Sponsor: Indiana University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumor

Start date: 2025-11-12
Primary completion: 2030-03-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.